Article info

Download PDFPDF

The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies

Authors

  • Dennis G McGonagle Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK NIHR Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton, Leeds Teaching Hospital Trust, Leeds, UK PubMed articlesGoogle scholar articles
  • Iain B McInnes Institute of Infection Immunity and Inflammation, University of Glasgow, Glasgow, UK PubMed articlesGoogle scholar articles
  • Bruce W Kirkham Rheumatology Department, Guy's and Saint Thomas' NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Jonathan Sherlock Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK PubMed articlesGoogle scholar articles
  • Robert Moots Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK Department of Academic Rheumatology, Aintree University Hospital, Liverpool, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Robert Moots, University of Liverpool Institute of Ageing and Chronic Disease, Liverpool, L9 7AL, UK; r.j.moots{at}liverpool.ac.uk
View Full Text

Citation

McGonagle DG, McInnes IB, Kirkham BW, et al
The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies

Publication history

  • Received March 8, 2019
  • Revised May 17, 2019
  • Accepted June 14, 2019
  • First published July 5, 2019.
Online issue publication 
August 12, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.